raziskovalne skupine - Stabilis 4.0

1

Stability of isoniazid injection in i.v. solutions.
Lee J, Moriyama B, Henning S, Danner R, Walsh T, Penzak S, Grimes G, Gopal K. (jun.lee@nih.gov)
Am J Health-Syst Pharm - 2018 - ; 75, 10: 622-626.

2

Stability of tacrolimus solutions in polyolefin containers.
Lee J.H, Goldspiel B.R, Ryu S, Potti G.K. (bgoldspiel@nih.gov)
Am J Health-Syst Pharm - 2016 - ; 73:137-142.

3

Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK. ()
Am J Health-Syst Pharm - 2001 - ; 58: 594-598.

4

Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK. ()
Am J Health-Syst Pharm - 1999 - ; 56: 985-989.

5

Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2423-2426.

6

Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
Lam NP, Kennedy PE, Jarosinski PF, Galleli JF. ()
Am J Hosp Pharm - 1991 - ; 48: 280-282.

7

Precipitation of ondansetron in alkaline solutions.
Jarosinski PF, Hirschfeld S. ()
N Engl J Med - 1991 - ; 325: 1315-1316.

8

Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. ()
Am J Hosp Pharm - 1990 - ; 47: 377-381.

9

Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Baltz JK, Kennedy P, Minor JR, Gallelli J. ()
Am J Hosp Pharm - 1990 - ; 47: 2075-2077.

10

Stability of a concentrated trimethoprim-sulfamethoxazole admixtures.
Jarosinski PF, Kennedy PE, Gallelli JF. ()
Am J Hosp Pharm - 1989 - ; 46: 732-737.

11

Visual compatibility of zidovudine with other drugs during simulated Y-site administration.
Bashaw ED, Amantea MA, Minor JR, Galleli JF. ()
Am J Hosp Pharm - 1988 - ; 45: 2532-2533.

12

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP. ()
Am J Hosp Pharm - 1987 - ; 44: 124-130.

13

Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW, Vishnuvajjala BR, Flora KP. ()
Am J Hosp Pharm - 1984 - ; 41: 1802-1806.

14

Stability of azacitidine in infusion fluids.
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP. ()
Am J Hosp Pharm - 1984 - ; 41: 1156-1159.

15

Photolytic degradation of adriamycin.
Tavoloni N, Guarino AM, Berck PD. ()
J Pharm Pharmacol - 1980 - ; 32: 860-862.

16

Stability of cisplatin in aqueous solution.
Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF. ()
Am J Hosp Pharm - 1979 - ; 36: 38-43.

17

Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
Cradock JC, Kleinmann LM, Rahman A. ()
Am J Hosp Pharm - 1978 - ; 35: 402-406.

18

Thermal and photolytic decomposition of methotrexate in aqueous solutions.
Chatterji D.C, Gallelli J.F. ()
J Pharm Sci - 1978 - ; 67, 4: 526-530.